Merck Mobius single-use bioreactors

Thursday, 14 September, 2017 | Supplied by: Merck Pty Ltd

Single-use, disposable equipment and systems have increased in popularity in the biopharmaceutical industry, offering advantages over conventional stainless steel systems including improved batch success rates, less cross-contamination risk, decreased water and wastewater requirements, and shortened project duration. At the same time, biopharmaceutical manufacturers are moving towards end-to-end solutions — from process development and scale-up through to manufacturing for preclinical, clinical and commercial supply — as they seek to increase quality and efficiency.

Merck’s portfolio of 3 to 2000 L Mobius single-use bioreactors delivers flexibility and continuity for scale-up, reducing the need for retraining operators. The bioreactors thus enable laboratories to streamline their processes and expand their capacity.

The bioreactors provide flexibility by configuring software, hardware and single-use assemblies for use in suspension and adherent cell culture applications. They can function as standalone systems or be integrated as part of a facility’s automation platform.

All systems have doors and viewing windows, providing easy access to expendables and visibility on the status of the working volume and mixing steps. CCP software meanwhile provides the user with one familiar interface that simplifies software management and reduces the learning curves for inexperienced operators.

Phone: 1800 800 097
Related Products

Beckman Coulter Life Sciences AQUIOS STEM System

Beckman Coulter Life Sciences' AQUIOS STEM System is a modular approach to automated and...

Navinci Diagnostics Naveni pY EGFR in situ proximity ligation assay kit

The Naveni pY EGFR is an in situ proximity ligation assay (PLA) kit for fluorescence detection of...

BioAuxilium THUNDER Total AKT pan TR-FRET Cell Signaling Assay Kit

The assay kit contains two specific and selective antibodies that recognise total (both...

  • All content Copyright © 2022 Westwick-Farrow Pty Ltd